Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
about
Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancerInhaled nano- and microparticles for drug deliveryNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesPEI-engineered respirable particles delivering a decoy oligonucleotide to NF-κB: inhibiting MUC2 expression in LPS-stimulated airway epithelial cellsFabrication of PLGA nanoparticles with a fluidic nanoprecipitation system.Dimensionality reduction, and function approximation of poly(lactic-co-glycolic acid) micro- and nanoparticle dissolution rate.Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.Inhalable oridonin-loaded poly(lactic-co-glycolic)acid large porous microparticles for in situ treatment of primary non-small cell lung cancer.Nanocarriers for pulmonary administration of peptides and therapeutic proteins.Lung vascular targeting through inhalation delivery: insight from filamentous viruses and other shapes.Advances in pulmonary delivery of nanoparticles.Strategies for non-invasive delivery of biologics.Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-κB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells.Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery.Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium.Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening.Novel biodegradable and pH-sensitive poly(ester amide) microspheres for oral insulin delivery.PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).Poly(glycerol adipate-co-ω-pentadecalactone) spray-dried microparticles as sustained release carriers for pulmonary delivery.Albumin-coated porous hollow poly(lactic-co-glycolic acid) microparticles bound with palmityl-acylated exendin-4 as a long-acting inhalation delivery system for the treatment of diabetes.One-Step Method to Prepare PLLA Porous Microspheres in a High-Voltage Electrostatic Anti-Solvent ProcessDevelopment of low density azithromycin-loaded polycaprolactone microparticles for pulmonary delivery.Disulfiram-loaded porous PLGA microparticle for inhibiting the proliferation and migration of non-small-cell lung cancer.Aerosolization, Drug Permeation and Cellular Interaction of Dry Powder Pulmonary Formulations of Corticosteroids with Hydroxypropyl-β-Cyclodextrin as a Solubilizer.Influence of polymeric carrier on the disposition and retention of 20(R)-ginsenoside-rg3-loaded swellable microparticles in the lung.Development of microspheres for biomedical applications: a review.Biodegradable, pH-responsive carboxymethyl cellulose/poly(acrylic acid) hydrogels for oral insulin delivery.Pharmacological and toxicological assessment of innovative self-assembled polymeric micelles as powders for insulin pulmonary delivery.Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery.pH- and thermo-responsive poly(N-isopropylacrylamide-co-acrylic acid derivative) copolymers and hydrogels with LCST dependent on pH and alkyl side groups
P2860
Q24614491-B73C5001-03F4-4304-8594-486CE9060404Q26771328-1CF11540-3CFA-48C7-B2E9-7D137B50545EQ26786162-19400F22-43CA-4692-8399-93ED416F30C9Q28484221-1F337776-EA55-4F43-A7B0-9F310E64B0F8Q34088052-D328CCBD-ABFD-406B-8840-AF00407B59ACQ35082000-E17E6A8C-E09B-43DB-8379-5E2922CC82EFQ35862967-64738128-4270-4448-BB03-827C2D7FB2C4Q37587394-C6F241AE-9099-4B5D-BF93-B66143C75283Q37823598-3DB454FF-53A2-4AC6-B9D5-317BA99CF2E2Q37896557-1157FC66-8F8D-42E6-9F9A-0167D4FAB064Q37909465-40BC615D-F8D2-46A2-A032-A1D57228FFD6Q38013190-D3B642B6-7B87-4A72-86B1-B23571B55D50Q38033610-A6454202-38F1-4E55-8A21-3804739AB9E4Q38195730-509E9D04-7672-4623-ABED-0F693FCBB6B6Q38337325-9C712B99-65E6-4C51-BCFE-0E21AF65168CQ38714479-39B59ECB-C019-4474-A54F-5275A16B67D1Q39261905-78C734E6-BCCC-4FA7-8126-0C11284A1984Q39338573-09735876-ADE1-435C-A1A8-751CFFDE3608Q39346006-DA88B191-EC4A-4C99-8FAE-709898145491Q39390938-41C45D6B-373F-47FC-BB9A-4591B4AA8935Q39533415-CEB5F510-8EC2-439C-8BB8-79489726A5DDQ39550161-A180CD5D-E485-4E68-9DF1-F57317FD9139Q39562651-CC587340-F2CF-4A01-9727-F2A5F38F200CQ40967808-80A97645-C581-4254-8D9A-9D8EFDA3CBAAQ41043744-D67D0611-1B9D-4F44-8FA6-A3402BCDA4AAQ41887816-1F266D3F-7DF4-486C-9D34-AC2D69F53774Q46492352-6D03A2BB-8B89-4E8E-887E-F979E4C86F6EQ48225478-8B8A1DB9-242B-4B7F-8B93-78E25446516FQ49204798-E219684D-270A-4531-AF61-AFD3ECDF9881Q51329737-7AF1A233-5376-49FB-BA08-DD7FDAC1D7F2Q51596702-E72A0249-3D11-4085-87D2-EEACF0C6F3EAQ53594400-97813525-FAD1-4199-8E0E-43E49ECD87F8Q57367967-5562E7AB-A0A4-436B-A768-F7676AE1869E
P2860
Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Insulin-loaded PLGA/cyclodextr ...... y after delivery to rat lungs.
@en
Insulin-loaded PLGA/cyclodextr ...... y after delivery to rat lungs.
@nl
type
label
Insulin-loaded PLGA/cyclodextr ...... y after delivery to rat lungs.
@en
Insulin-loaded PLGA/cyclodextr ...... y after delivery to rat lungs.
@nl
prefLabel
Insulin-loaded PLGA/cyclodextr ...... y after delivery to rat lungs.
@en
Insulin-loaded PLGA/cyclodextr ...... y after delivery to rat lungs.
@nl
P50
P1476
Insulin-loaded PLGA/cyclodextr ...... y after delivery to rat lungs.
@en
P2093
Concetta Giovino
Maria Immacolata La Rotonda
P356
10.1016/J.JCONREL.2008.12.011
P407
P50
P577
2008-12-25T00:00:00Z